ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01260103
Recruitment Status : Withdrawn (Withdrawn: study halted prematurely, prior to enrollment of first participant)
First Posted : December 15, 2010
Last Update Posted : July 26, 2017
Sponsor:
Information provided by (Responsible Party):
Burzynski Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2018